Functional magnetic nanoparticles for bioactive protein delivery under physiological temperature

Current therapies for tissue damage, especially in bone repair, are limited by invasiveness and susceptibility to infection. The clinical problem of nonunions —fractures that fail to heal completely within the expected clinical timeframe 5–10% of annual fractures, underscores the need for less invasive and more targeted treatments. Successful bone regeneration relies on mesenchymal stem cells (MSCs) differentiating into osteoblasts, a critical process driven by bioactive signalling molecules. To overcome the limitations of current pharmaceutical interventions and surgical grafts, which include high-dosage side effects and a lack of controlled release, this research aims to develop a drug delivery system.
This study investigates temperature sensitive polymer poly(-isopropylmethacrylamide) (PNIPMAM)-coated superparamagnetic iron oxide nanoparticles (SPIONs) as a thermo-responsive platform for the delivery of the osteo-inducive growth factors. pPrimary objective was to optimize the synthesis of PNIPMAM-coated SPIONs to ensure a reproducible and stable formulation. This was achieved by refining the coating process, resulting in a consistent polymer coating with confirming lower critical solution temperature (LCST) above physiological temperature. Biocompatibility assessments using the Y201 MSC line confirmed the coated nanoparticles are non-toxic at concentrations up to 1 mg/ml and do not interfere with osteogenic differentiation on their own, establishing a crucial baseline for subsequent bioactivity assays.
The system achieved high BMP2 encapsulation efficiency ~95% with bioactivity quantified via ALP activity in C2C12 cells. However, there was no release of BMP2 under the tested conditions. Conversely, delivering the thermally unstable Wnt3a was successful by incorporating glycerol as a thermos-stabilizing additive, which also lowered the polymer's LCST at physiologically relevant temperature. This optimized system conclusively demonstrated a temperature-triggered, bioactive Wnt3a release, particularly with apotransferrin as a competitor protein.
In conclusion, this work establishes PNIPMAM-coated SPIONs as a potential viable platform for encapsulating and enabling on-demand, localized delivery of osteogenic factors. The findings highlight the critical influence of protein-specific characteristics and the formulation’s biochemical environment on release efficiency, providing a strong foundation for future advancements in regenerative medicine.